699,863 New Shares Issued upon Conversion of Convertible Bonds (3.18% Dilution)
-
699,863 new shares issued upon conversion of 2.6 billion won of 33rd-series private convertible bonds (conversion price: 3,715 won)
-
New shares listing date: 2026-06-02; dilution of 3.18% relative to total outstanding shares
-
Remaining unconverted bonds: 7 billion won (conversion price: 3,715 won); conversion period expired (until 2026-05-11)
KOSPI Filing Information
-
Filing: Exercise Of Conversion Rights, Stock Subscription Rights, And Exchange Rights
-
Company: PharmGen Science (004720)
-
Submission: PharmGen Science, Inc.
-
Receipt: 05-12-2026
-
Under KRX KOSPI Market Division